Proclear 1-D Multifocal Nondispensing Study

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Presbyopia
Interventions
DEVICE

omafilcon A / PC 1-D MF

Subjects were randomly assigned into either the omafilcon A/PC 1-D MF lenses with +0.75D over-correction in the non-dominant eye or the lotrafilcon B/Air Optix MF lenses then crossed-over into the alternative pair of study lenses.

DEVICE

lotrafilcon B / Air Optix MF

Subjects were randomly assigned into either the omafilcon A/PC 1-D MF lenses with +0.75D over-correction in the non-dominant eye or the lotrafilcon B/Air Optix MF lenses then crossed-over into the alternative pair of study lenses

Trial Locations (1)

47405

Clinical Optics Research Lab, Indiana University,, Bloomington

All Listed Sponsors
lead

CooperVision, Inc.

INDUSTRY

NCT01526902 - Proclear 1-D Multifocal Nondispensing Study | Biotech Hunter | Biotech Hunter